Can a simple program help new moms and their babies thrive?

NCT ID NCT07627373

Not yet recruiting Symptom relief Sponsor: Stanford University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a group-based program called the Thinking Healthy Extended Program (THEP) for new mothers with mild to moderate depression. The program is delivered at community health centers in China and aims to improve maternal mental health and child development. Researchers will compare 440 mothers who receive the program with those who get usual care, tracking depression, parenting stress, and child outcomes over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Thinking Healthy Extended Program (group-based psychosocial intervention)
What this could lead to: If it works, this could provide a scalable way to support new mothers' mental health and boost early child development through routine healthcare visits.
What could go wrong: This is a relatively small trial (440 participants) testing a behavioral program, not a drug. Results may not apply to all settings, and the program may not significantly improve outcomes compared to usual care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSIVE SYMPTOMS, POSTPARTUM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression postpartum depression

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEPRESSIVE SYMPTOMS, POSTPARTUM EARLY CHILD DEVELOPMENT MATERNAL MENTAL HEALTH

Contacts and locations

Locations

5 Community Health Centers in Pudong District, Shanghai

Shanghai, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.